1. Cholangiocyte myosin IIB is required for localized aggregation of sodium glucose cotransporter 1 to sites of Cryptosporidium parvum cellular invasion and facilitates parasite internalization.
- Author
-
O'Hara SP, Gajdos GB, Trussoni CE, Splinter PL, and LaRusso NF
- Subjects
- Aquaporin 1 physiology, Bile Ducts cytology, Bile Ducts parasitology, Blotting, Western, Cell Line, Cryptosporidium parvum physiology, Fluorescent Antibody Technique, Heterocyclic Compounds, 4 or More Rings pharmacology, Host-Parasite Interactions physiology, Humans, Microscopy, Electron, Scanning, Nonmuscle Myosin Type IIA physiology, Reverse Transcriptase Polymerase Chain Reaction, Sodium-Glucose Transporter 1 antagonists & inhibitors, Cryptosporidiosis parasitology, Cryptosporidium parvum pathogenicity, Nonmuscle Myosin Type IIB physiology, Sodium-Glucose Transporter 1 physiology
- Abstract
Internalization of the obligate intracellular apicomplexan parasite, Cryptosporidium parvum, results in the formation of a unique intramembranous yet extracytoplasmic niche on the apical surfaces of host epithelial cells, a process that depends on host cell membrane extension. We previously demonstrated that efficient C. parvum invasion of biliary epithelial cells (cholangiocytes) requires host cell actin polymerization and localized membrane translocation/insertion of Na(+)/glucose cotransporter 1 (SGLT1) and of aquaporin 1 (Aqp1), a water channel, at the attachment site. The resultant localized water influx facilitates parasite cellular invasion by promoting host-cell membrane protrusion. However, the molecular mechanisms by which C. parvum induces membrane translocation/insertion of SGLT1/Aqp1 are obscure. We report here that cultured human cholangiocytes express several nonmuscle myosins, including myosins IIA and IIB. Moreover, C. parvum infection of cultured cholangiocytes results in the localized selective aggregation of myosin IIB but not myosin IIA at the region of parasite attachment, as assessed by dual-label immunofluorescence confocal microscopy. Concordantly, treatment of cells with the myosin light chain kinase inhibitor ML-7 or the myosin II-specific inhibitor blebbistatin or selective RNA-mediated repression of myosin IIB significantly inhibits (P < 0.05) C. parvum cellular invasion (by 60 to 80%). Furthermore ML-7 and blebbistatin significantly decrease (P < 0.02) C. parvum-induced accumulation of SGLT1 at infection sites (by approximately 80%). Thus, localized actomyosin-dependent membrane translocation of transporters/channels initiated by C. parvum is essential for membrane extension and parasite internalization, a phenomenon that may also be relevant to the mechanisms of cell membrane protrusion in general.
- Published
- 2010
- Full Text
- View/download PDF